Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 59 entries
Sorted by: Best Match Show Resources per page
Role of medical journals in adverse drug reaction alerts.

Lancet (London, England)

Haramburu F, Begaud B, Pere JC, Marcel S, Albin H.
PMID: 2863560
Lancet. 1985 Sep 07;2(8454):550-1. doi: 10.1016/s0140-6736(85)90480-5.

No abstract available.

Cite
Haramburu F, Begaud B, Pere JC, et al. Role of medical journals in adverse drug reaction alerts. Lancet. 1985;2(8454):550-1doi: 10.1016/s0140-6736(85)90480-5.
Haramburu, F., Begaud, B., Pere, J. C., Marcel, S., & Albin, H. (1985). Role of medical journals in adverse drug reaction alerts. Lancet (London, England), 2(8454), 550-1. https://doi.org/10.1016/s0140-6736(85)90480-5
Haramburu, F, et al. "Role of medical journals in adverse drug reaction alerts." Lancet (London, England) vol. 2,8454 (1985): 550-1. doi: https://doi.org/10.1016/s0140-6736(85)90480-5
Haramburu F, Begaud B, Pere JC, Marcel S, Albin H. Role of medical journals in adverse drug reaction alerts. Lancet. 1985 Sep 07;2(8454):550-1. doi: 10.1016/s0140-6736(85)90480-5. PMID: 2863560.
Copy Download .nbib Format: NLM
Complete Genome Sequence of a Tomato Isolate of Parietaria Mottle Virus from Italy.

Genome announcements

Martínez C, Aramburu J, Rubio L, Galipienso L.
PMID: 26679580
Genome Announc. 2015 Dec 17;3(6). doi: 10.1128/genomeA.01452-15.

We report here the complete genome sequence of isolate T32 of parietaria mottle virus (PMoV) infecting tomato plants in Turin, Italy, obtained by Sanger sequencing. T32 shares 90.48 to 96.69% nucleotide identity with other two PoMV isolates, CR8 and...

Cite
Martínez C, Aramburu J, Rubio L, et al. Complete Genome Sequence of a Tomato Isolate of Parietaria Mottle Virus from Italy. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01452-15.
Martínez, C., Aramburu, J., Rubio, L., & Galipienso, L. (2015). Complete Genome Sequence of a Tomato Isolate of Parietaria Mottle Virus from Italy. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01452-15
Martínez, Carolina, et al. "Complete Genome Sequence of a Tomato Isolate of Parietaria Mottle Virus from Italy." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01452-15
Martínez C, Aramburu J, Rubio L, Galipienso L. Complete Genome Sequence of a Tomato Isolate of Parietaria Mottle Virus from Italy. Genome Announc. 2015 Dec 17;3(6). doi: 10.1128/genomeA.01452-15. PMID: 26679580; PMCID: PMC4683225.
Copy Download .nbib Format: NLM
Compact spot-size converters with fiber-matched antiresonant reflecting optical waveguides.

Applied optics

Galarza M, De Mesel K, Baets R, Martínez A, Aramburu C, López-Amo M.
PMID: 12952328
Appl Opt. 2003 Aug 20;42(24):4841-6. doi: 10.1364/ao.42.004841.

We propose a concept for InGaAsP-InP 1.55-microm lasers integrated with spot-size converters based on modal interference between the modes of the structure formed by an active waveguide and an underlying fiber-matched antiresonant reflecting optical waveguide. Simulation results show that...

Cite
Galarza M, De Mesel K, Baets R, et al. Compact spot-size converters with fiber-matched antiresonant reflecting optical waveguides. Appl Opt. 2003;42(24):4841-6doi: 10.1364/ao.42.004841.
Galarza, M., De Mesel, K., Baets, R., Martínez, A., Aramburu, C., & López-Amo, M. (2003). Compact spot-size converters with fiber-matched antiresonant reflecting optical waveguides. Applied optics, 42(24), 4841-6. https://doi.org/10.1364/ao.42.004841
Galarza, Marko, et al. "Compact spot-size converters with fiber-matched antiresonant reflecting optical waveguides." Applied optics vol. 42,24 (2003): 4841-6. doi: https://doi.org/10.1364/ao.42.004841
Galarza M, De Mesel K, Baets R, Martínez A, Aramburu C, López-Amo M. Compact spot-size converters with fiber-matched antiresonant reflecting optical waveguides. Appl Opt. 2003 Aug 20;42(24):4841-6. doi: 10.1364/ao.42.004841. PMID: 12952328.
Copy Download .nbib Format: NLM
Phenomenological model for type-II incommensurate phases having a soliton regime: Thiourea case.

Physical review. B, Condensed matter

Aramburu I, Madariaga G, Pérez-Mato JM.
PMID: 10010381
Phys Rev B Condens Matter. 1994 Jan 01;49(2):802-814. doi: 10.1103/physrevb.49.802.

No abstract available.

Cite
Aramburu I, Madariaga G, Pérez-Mato JM. Phenomenological model for type-II incommensurate phases having a soliton regime: Thiourea case. Phys Rev B Condens Matter. 1994;49(2):802-814doi: 10.1103/physrevb.49.802.
Aramburu, I., Madariaga, G., & Pérez-Mato, J. M. (1994). Phenomenological model for type-II incommensurate phases having a soliton regime: Thiourea case. Physical review. B, Condensed matter, 49(2), 802-814. https://doi.org/10.1103/physrevb.49.802
Aramburu, et al. "Phenomenological model for type-II incommensurate phases having a soliton regime: Thiourea case." Physical review. B, Condensed matter vol. 49,2 (1994): 802-814. doi: https://doi.org/10.1103/physrevb.49.802
Aramburu I, Madariaga G, Pérez-Mato JM. Phenomenological model for type-II incommensurate phases having a soliton regime: Thiourea case. Phys Rev B Condens Matter. 1994 Jan 01;49(2):802-814. doi: 10.1103/physrevb.49.802. PMID: 10010381.
Copy Download .nbib Format: NLM
Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Aramburu C, Harbarth S, Liassine N, Girard M, Gervaix A, Scherenzel J, Renzi G, Sudre P.
PMID: 29208105
Euro Surveill. 2006 Jan;11(1):11-12. doi: 10.2807/esm.11.01.00594-en.

Methicillin resistant Staphylococcus Aureus (MRSA) infection is an emerging community pathogen. Community-acquired MRSA (CA-MRSA) has been associated with virulent strains producing Panton-Valentine leukocidin (PVL) and a variety of other exotoxins. In Geneva, PVL-producing CA-MRSA was first reported in 2002...

Cite
Aramburu C, Harbarth S, Liassine N, et al. Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report. Euro Surveill. 2006;11(1):11-12doi: 10.2807/esm.11.01.00594-en.
Aramburu, C., Harbarth, S., Liassine, N., Girard, M., Gervaix, A., Scherenzel, J., Renzi, G., & Sudre, P. (2006). Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 11(1), 11-12. https://doi.org/10.2807/esm.11.01.00594-en
Aramburu, C, et al. "Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report." Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin vol. 11,1 (2006): 11-12. doi: https://doi.org/10.2807/esm.11.01.00594-en
Aramburu C, Harbarth S, Liassine N, Girard M, Gervaix A, Scherenzel J, Renzi G, Sudre P. Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report. Euro Surveill. 2006 Jan;11(1):11-12. doi: 10.2807/esm.11.01.00594-en. PMID: 29208105.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Le Louët H, Loupi E, Haramburu F.
PMID: 27393409
Therapie. 2007 May-Jun;62(3):241-4. doi: 10.2515/therapie:2007048.

Le vaccin est un médicament biologique (le plus souvent anti-infectieux) administré dans un but le plus souvent préventif, dont l'effet n'est pas pharmacologique mais immunologique. Il doit être évalué par les techniques habituelles de la pharmacologie clinique et de...

Cite
Le Louët H, Loupi E, Haramburu F. Quelle pharmacovigilance pour les vaccins ? [Not Available]. Therapie. 2007;62(3):241-4doi: 10.2515/therapie:2007048.
Le Louët, H., Loupi, E., Haramburu, F. (2007). Quelle pharmacovigilance pour les vaccins ? [Not Available]. Therapie, 62(3), 241-4. https://doi.org/10.2515/therapie:2007048
Le Louët, Hervé, et al. "Quelle pharmacovigilance pour les vaccins ?" [Not Available]. Therapie vol. 62,3 (2007): 241-4. doi: https://doi.org/10.2515/therapie:2007048
Le Louët H, Loupi E, Haramburu F. Quelle pharmacovigilance pour les vaccins ? [Not Available]. Therapie. 2007 May-Jun;62(3):241-4. doi: 10.2515/therapie:2007048. French. PMID: 27393409.
Copy Download .nbib Format: NLM
Radiotherapy treatment in benign osteoarticular disease.

Reumatologia clinica

Aramburu F, Montero A, Cabrera Alarcón JL, García de la Peña-Lefevre P.
PMID: 34823831
Reumatol Clin (Engl Ed). 2021 Dec;17(10):624-625. doi: 10.1016/j.reumae.2020.03.001. Epub 2020 Nov 23.

No abstract available.

Cite
Aramburu F, Montero A, Cabrera Alarcón JL, et al. Radiotherapy treatment in benign osteoarticular disease. Reumatol Clin (Engl Ed). 2020;17(10):624-625doi: 10.1016/j.reumae.2020.03.001.
Aramburu, F., Montero, A., Cabrera Alarcón, J. L., & García de la Peña-Lefevre, P. (2021). Radiotherapy treatment in benign osteoarticular disease. Reumatologia clinica, 17(10), 624-625. https://doi.org/10.1016/j.reumae.2020.03.001
Aramburu, Francisco, et al. "Radiotherapy treatment in benign osteoarticular disease." Reumatologia clinica vol. 17,10 (2021): 624-625. doi: https://doi.org/10.1016/j.reumae.2020.03.001
Aramburu F, Montero A, Cabrera Alarcón JL, García de la Peña-Lefevre P. Radiotherapy treatment in benign osteoarticular disease. Reumatol Clin (Engl Ed). 2021 Dec;17(10):624-625. doi: 10.1016/j.reumae.2020.03.001. Epub 2020 Nov 23. PMID: 34823831.
Copy Download .nbib Format: NLM
Stroke Work Damping Ratio is Increased in Trained Athletes.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Lemes Coitinho L, Cymberknop LJ, Farro I, Martinez F, Americo C, Lluberas N, Parma G, Aramburu J, Armentano RL.
PMID: 34892377
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:5531-5534. doi: 10.1109/EMBC46164.2021.9630513.

INTRODUCTION: Athletes training is often associated with morphological changes in the heart. In this sense, the ventricular pressure-volume (PV) relation provides a complete characterization of cardiac pump performance. Regarding the arterial system (AS), arterial wall viscosity is a source...

Cite
Lemes Coitinho L, Cymberknop LJ, Farro I, et al. Stroke Work Damping Ratio is Increased in Trained Athletes. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:5531-5534doi: 10.1109/EMBC46164.2021.9630513.
Lemes Coitinho, L., Cymberknop, L. J., Farro, I., Martinez, F., Americo, C., Lluberas, N., Parma, G., Aramburu, J., & Armentano, R. L. (2021). Stroke Work Damping Ratio is Increased in Trained Athletes. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20215531-5534. https://doi.org/10.1109/EMBC46164.2021.9630513
Lemes Coitinho, L, et al. "Stroke Work Damping Ratio is Increased in Trained Athletes." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 5531-5534. doi: https://doi.org/10.1109/EMBC46164.2021.9630513
Lemes Coitinho L, Cymberknop LJ, Farro I, Martinez F, Americo C, Lluberas N, Parma G, Aramburu J, Armentano RL. Stroke Work Damping Ratio is Increased in Trained Athletes. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:5531-5534. doi: 10.1109/EMBC46164.2021.9630513. PMID: 34892377.
Copy Download .nbib Format: NLM
Arterial-Ventricular Coupling Impairment is Evidenced in Both Normal and Ischemic Subjects by Applying Cluster Analysis.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Aguirre N, Cymberknop LJ, Farro I, Americo C, Martinez F, Grall E, Lluberas N, Parma G, Aramburu J, Armentano RL.
PMID: 34892391
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:5590-5593. doi: 10.1109/EMBC46164.2021.9629812.

INTRODUCTION: Left ventricular (LV) interaction with the arterial system (arterial-ventricular coupling, AVC) is a central determinant of cardiovascular performance and cardiac energetics. Stress Echocardiography (SE) constitutes a valuable clinical tool in both diagnosis and risk stratification of patients with...

Cite
Aguirre N, Cymberknop LJ, Farro I, et al. Arterial-Ventricular Coupling Impairment is Evidenced in Both Normal and Ischemic Subjects by Applying Cluster Analysis. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:5590-5593doi: 10.1109/EMBC46164.2021.9629812.
Aguirre, N., Cymberknop, L. J., Farro, I., Americo, C., Martinez, F., Grall, E., Lluberas, N., Parma, G., Aramburu, J., & Armentano, R. L. (2021). Arterial-Ventricular Coupling Impairment is Evidenced in Both Normal and Ischemic Subjects by Applying Cluster Analysis. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20215590-5593. https://doi.org/10.1109/EMBC46164.2021.9629812
Aguirre, N, et al. "Arterial-Ventricular Coupling Impairment is Evidenced in Both Normal and Ischemic Subjects by Applying Cluster Analysis." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 5590-5593. doi: https://doi.org/10.1109/EMBC46164.2021.9629812
Aguirre N, Cymberknop LJ, Farro I, Americo C, Martinez F, Grall E, Lluberas N, Parma G, Aramburu J, Armentano RL. Arterial-Ventricular Coupling Impairment is Evidenced in Both Normal and Ischemic Subjects by Applying Cluster Analysis. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:5590-5593. doi: 10.1109/EMBC46164.2021.9629812. PMID: 34892391.
Copy Download .nbib Format: NLM
A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization.

Scientific reports

Antón R, Antoñana J, Aramburu J, Ezponda A, Prieto E, Andonegui A, Ortega J, Vivas I, Sancho L, Sangro B, Bilbao JI, Rodríguez-Fraile M.
PMID: 33594143
Sci Rep. 2021 Feb 16;11(1):3895. doi: 10.1038/s41598-021-83414-7.

Radioembolization (RE) with yttrium-90 (

Cite
Antón R, Antoñana J, Aramburu J, et al. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization. Sci Rep. 2021;11(1):3895doi: 10.1038/s41598-021-83414-7.
Antón, R., Antoñana, J., Aramburu, J., Ezponda, A., Prieto, E., Andonegui, A., Ortega, J., Vivas, I., Sancho, L., Sangro, B., Bilbao, J. I., & Rodríguez-Fraile, M. (2021). A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization. Scientific reports, 11(1), 3895. https://doi.org/10.1038/s41598-021-83414-7
Antón, Raúl, et al. "A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization." Scientific reports vol. 11,1 (2021): 3895. doi: https://doi.org/10.1038/s41598-021-83414-7
Antón R, Antoñana J, Aramburu J, Ezponda A, Prieto E, Andonegui A, Ortega J, Vivas I, Sancho L, Sangro B, Bilbao JI, Rodríguez-Fraile M. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization. Sci Rep. 2021 Feb 16;11(1):3895. doi: 10.1038/s41598-021-83414-7. PMID: 33594143; PMCID: PMC7886872.
Copy Download .nbib Format: NLM
In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization.

Biology

Aramburu J, Antón R, Fukamizu J, Nozawa D, Takahashi M, Ozaki K, Ramos JC, Sangro B, Bilbao JI, Tomita K, Matsumoto T, Hasebe T.
PMID: 34943256
Biology (Basel). 2021 Dec 16;10(12). doi: 10.3390/biology10121341.

BACKGROUND: Balloon-occluded transarterial chemoembolization (B-TACE) has emerged as a safe and effective procedure for patients with liver cancer, which is one of the deadliest types of cancer worldwide. B-TACE consist of the transcatheter intraarterial infusion of chemotherapeutic agents, followed...

Cite
Aramburu J, Antón R, Fukamizu J, et al. In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization. Biology (Basel). 2021;10(12)doi: 10.3390/biology10121341.
Aramburu, J., Antón, R., Fukamizu, J., Nozawa, D., Takahashi, M., Ozaki, K., Ramos, J. C., Sangro, B., Bilbao, J. I., Tomita, K., Matsumoto, T., & Hasebe, T. (2021). In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization. Biology, 10(12), . https://doi.org/10.3390/biology10121341
Aramburu, Jorge, et al. "In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization." Biology vol. 10,12 (2021). doi: https://doi.org/10.3390/biology10121341
Aramburu J, Antón R, Fukamizu J, Nozawa D, Takahashi M, Ozaki K, Ramos JC, Sangro B, Bilbao JI, Tomita K, Matsumoto T, Hasebe T. In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization. Biology (Basel). 2021 Dec 16;10(12). doi: 10.3390/biology10121341. PMID: 34943256.
Copy Download .nbib Format: NLM
A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019).

Drug safety

Perri-Plandé J, Miremont-Salamé G, Micallef J, Herman C, Baumevieille M, Abriat F, Lapeyre-Mestre M, Haramburu F, Daveluy A.
PMID: 34714529
Drug Saf. 2021 Oct 29; doi: 10.1007/s40264-021-01124-5. Epub 2021 Oct 29.

INTRODUCTION: Analgesics are among the most widely used drugs worldwide. This study describes the population treated with narcotic analgesics, their therapeutic indications and how the data have evolved over a decade.METHODS: A cross-sectional, national, multicentre survey study was conducted...

Cite
Perri-Plandé J, Miremont-Salamé G, Micallef J, et al. A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019). Drug Saf. 2021;doi: 10.1007/s40264-021-01124-5.
Perri-Plandé, J., Miremont-Salamé, G., Micallef, J., Herman, C., Baumevieille, M., Abriat, F., Lapeyre-Mestre, M., Haramburu, F., Daveluy, A. (2021). A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019). Drug safety, . https://doi.org/10.1007/s40264-021-01124-5
Perri-Plandé, Joelle, et al. "A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019)." Drug safety vol. (2021). doi: https://doi.org/10.1007/s40264-021-01124-5
Perri-Plandé J, Miremont-Salamé G, Micallef J, Herman C, Baumevieille M, Abriat F, Lapeyre-Mestre M, Haramburu F, Daveluy A. A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019). Drug Saf. 2021 Oct 29; doi: 10.1007/s40264-021-01124-5. Epub 2021 Oct 29. PMID: 34714529.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 59 entries